Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XUL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $36,133
Award facts
- Contract value 100% obligated
- $36,133.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,133.14 on September 25, 2025, for the supply of Jakafi 10 mg tablets (60-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status. The place of performance is Park Ridge, Illinois, where the vendor maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. Jakafi, an oncology medication, represents one of the specialized pharmaceutical products the company distributes as part of this broader federal supply arrangement. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a consistent portfolio of pharmaceutical delivery orders to military health facilities.
Quick answers
Who was awarded contract SPE2DX25F6XUL?
SPE2DX25F6XUL was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 25, 2025.
How much is contract SPE2DX25F6XUL worth?
The government has obligated $36,133 on SPE2DX25F6XUL.
Is contract SPE2DX25F6XUL an order under another contract?
Yes. SPE2DX25F6XUL is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XUL competed?
The extent of competition for SPE2DX25F6XUL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award